NEW YORK, March 11, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Kornit Digital Ltd. (“Kornit ” or the “Company”) (NASDAQ: KRNT) and reminds investors of the April 17, 2023 deadline to seek the role of lead…

NEW YORK, March 11, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Allianz SE (“Allianz” or the “Company”) (OTC: ALIZY) and reminds investors of the April 3, 2023 deadline to seek the role of lead plaintiff in a…

NEW YORK, March 11, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Catalent, Inc. (“Catalent” or the “Company”) (NYSE: CTLT) and reminds investors of the April 25, 2023 deadline to seek the role of lead…

NEW YORK, March 11, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lumen Technologies, Inc. (“Lumen” or the “Company”) (NYSE: LUMN) and reminds investors of the May 2, 2023 deadline to seek the role of lead…

NEW YORK, March 11, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BlockFi, Inc. (“BlockFi” or the “Company”) and reminds investors of the May 1, 2023 deadline to seek the role of lead plaintiff in a federal…

NEW YORK, March 11, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cognyte Software, Ltd. (“Cognyte” or the “Company”) (NASDAQ: CGNT) and reminds investors of the May 1, 2023 deadline to seek the role of lead…

NEW YORK, March 11, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Bioventus Inc. (“Bioventus” or the “Company”) (NASDAQ: BVS) and reminds investors of the March 13, 2023 deadline to seek the role of lead…

NEW YORK, March 11, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”) (NASDAQ: YMAB) and reminds investors of the March 20, 2023 deadline to seek the role of…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.